Sotera Health Company SHC
16.28 USD +0.23 (+1.43%)
Regular-session close
16.32 +0.04 +0.25%
After hours · Nov 18, 4:01 PM ET
15.97 Day range 16.41
13.09 52-week range 19.85
- YTD
- -7.71%
- 1 year
- +6.89%
News
seekingalpha.com Sotera Health Company (SHC) Presents at Jefferies Global Healthcare Conference 2026 Transcript Sotera Health Company (SHC) Presents at Jefferies Global Healthcare Conference 2026 Transcript
benzinga.com David Einhorn Bets on Aluminum in Q3: Here Are His New Stock Picks, Fund Changes DME Capital Management reveals its new third-quarter stock picks. Here's what David Einhorn has been buying.
zacks.com Do Options Traders Know Something About Sotera Health Stock We Don't? Investors need to pay close attention to SHC stock based on the movements in the options market lately.benzinga.com JP Morgan Maintains Underweight on Sotera Health, Lowers Price Target to $15 JP Morgan analyst Casey Woodring maintains Sotera Health (NASDAQ:SHC) with a Underweight and lowers the price target from $17 to $15.
benzinga.com Barclays Maintains Overweight on Sotera Health, Lowers Price Target to $20 Barclays analyst Luke Sergott maintains Sotera Health (NASDAQ:SHC) with a Overweight and lowers the price target from $22 to $20.
benzinga.com Sotera Health Q3 2026 Earnings Call Transcript Sotera Health (NASDAQ:SHC) reported third-quarter financial results on Tuesday. The transcript from the company’s third-quarter earnings call has been provided below.This transcript is brought to you…benzinga.com Sotera Health Q3 Adj. EPS $0.29 Beats $0.27 Estimate, Sales $324.886M Beat $319.774M Estimate Sotera Health (NASDAQ:SHC) reported quarterly earnings of $0.29 per share which beat the analyst consensus estimate of $0.27 by 7.41 percent. This is a 11.54 percent increase over earnings of $0.26…
benzinga.com Sotera Health Affirms FY2026 Adj EPS Guidance of $0.95-$1.01 vs $0.98 Est; Lowers FY2026 Sales Guidance from $1.236B-$1.254B to $1.233B-$1.250B vs $1.247B Est Sotera Health (NASDAQ:SHC) affirms FY2026 Adj EPS guidance from $0.95-$1.01 to $0.95-$1.01 vs $0.98 analyst estimate. Lowers FY2026 sales outlook from $1.236 billion-$1.254 billion to $1.233…
